Imaging and Percutaneous Treatment of Vascular Anomalies

Sandeep Vaidya; Daniel Cooke; Matthew Kogut; Peter G. Stratil; Mark A. Bittles; Manrita Sidhu

doi:10.1055/s-0028-1085921

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2008; 25(3): 216-233
DOI: 10.1055/s-0028-1085921

Imaging and Percutaneous Treatment of Vascular Anomalies

Sandeep Vaidya¹ , Daniel Cooke¹ , Matthew Kogut¹ , Peter G. Stratil¹ , Mark A. Bittles² , Manrita Sidhu³

¹Department of Radiology, University of Washington, Seattle, Washington
²Vanderbilt University and Vanderbilt Children's Hospital, Nashville, Tennessee
³Children's Hospital and Regional Medical Center, University of Washington, Seattle Radiologists Advanced Imaging Center, Everett, Washington

Abstract

ABSTRACT

Vascular anomalies are an extensive group of malformations of the arterial, venous, and lymphatic systems, either in isolation or, more often, in combination. Although mostly congenital, they can occasionally be acquired as well. They present a challenge both for workup and therapy. This article attempts to describe some of their main anomalies, their workup, and their therapies, with the goal of increasing the comfort level of endovascular therapists.

KEYWORDS

Vascular anomalies - malformations - hemangiomas - percutaneous endovascular therapy - embolization

Full Text

References

REFERENCES

1 Mulliken J B, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982; 69(3) 412-422
2 JK W, TS L, CT R et al. For hemangiomas refractory to first line corticosteroid therapy, interferon and vincristine therapy has been described. In, International Society for the Study of Vascular Anomalies. Wellington, New Zealand; 2004
3 Chang M W. Updated classification of hemangiomas and other vascular anomalies. Lymphat Res Biol. 2003; 1(4) 259-265
4 Upton J, Coombs C J, Mulliken J B, Burrows P E, Pap S. Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg [Am]. 1999; 24(5) 1019-1035
5 Cho S K, Do Y S, Shin S W, Kim D I et al.. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther. 2006; 13 527-538
6 Jacobowitz G, Rosen R J, Rockman C B et al.. Transcatheter embolization of complex pelvic vascular malformations: results and long-term follow-up. J Vasc Surg. 2001; 33(1) 51-55
7 Hadizadeh D R, von Falkenhausen M, Gieseke J et al.. Cerebral arteriovenous malformation: Spetzler-Martin classification at subsecond-temporal-resolution four-dimensional MR angiography compared with that at DSA. Radiology. 2008; 246(1) 205-213
8 Bittles M A, Sidhu M K, Sze R W et al.. Multidetector CT angiography of pediatric vascular malformations and hemangiomas: utility of 3-D reformatting in differential diagnosis. Pediatr Radiol. 2005; 35(11) 1100-1106
9 Ohgiya Y, Hashimoto T, Gokan T. Dynamic MRI for Distinguishing High-flow from Low-flow peripheral vascular malformations. AJR Am J Roentgenol. 2005; 185(5) 1131-1137
10 Lee B B, Do Y S, Yakes W, Kim D I, Mattassi R, Hyon W S. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg. 2004; 39(3) 590-600
11 Do Y S, Yakes W F, Shin S W et al.. ethanol embolization of arteriovenous malformations: interim results. Radiology. 2005; 235(2) 674-682
12 Jordan O, Doelker E, Rufenacht D A. Biomaterials used in injectable implants (liquid embolics) for percutaneous filling of vascular spaces. Cardiovasc Intervent Radiol. 2005; 28(5) 561-569
13 Osuga K, Hori S, Kitayoshi H et al.. Embolization of high flow arteriovenous malformations: experience with use of superabsorbent polymer microspheres. J Vasc Interv Radiol. 2002; 13(11) 1125-1133
14 Yakes W F, Haas D K, Parker S H et al.. Symptomatic vascular malformations: ethanol embolotherapy. Radiology. 1989; 170(3 Pt 2) 1059-1066
15 White Jr R I, Pollak J, Persing J et al.. Long-term outcome of embolotherapy and surgery for high-flow extremity arteriovenous malformations. J Vasc Interv Radiol. 2000; 11(10) 1285-1295
16 Vikkula M, Boon L, Mulliken J. Molecular genetics of vascular malformations. Matrix Biol. 2001; 20(5–6) 327-335
17 Burrows P E, Mason K P. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol. 2004; 15(5) 431-445
18 Claudon M, Upton J, Burrows P. Diffuse venous malformations of the upper limb: morphologic characterization by MRI and venography. Pediatr Radiol. 2001; 31(7) 507-514
19 Ohlms L A, Forsen J, Burrows P E. Venous malformation of the pediatric airway. Int J Pediatr Otorhinolaryngol. 1996; 37(2) 99-114
20 Mason K P, Neufeld E J, Karian V E et al.. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies. AJR Am J Roentgenol. 2001; 177(6) 1359-1363
21 van Rijswijk C S, van der Linden E, van der Woude H J, van Baalen J M, Bloem J L. Value of dynamic contrast-enhanced MR imaging in diagnosing and classifying peripheral vascular malformations. AJR Am J Roentgenol. 2002; 178(5) 1181-1187
22 Dobson M J, Hartley R W, Ashleigh R, Watson Y, Hawnaur J M. MR angiography and MR imaging of symptomatic vascular malformations. Clin Radiol. 1997; 52(8) 595-602
23 Kim E Y, Ahn J M, Yoon H K et al.. Intramuscular vascular malformations of an extremity: findings on MR imaging and pathologic correlation. Skeletal Radiol. 1999; 28(9) 515-521
24 Herborn C U, Goyen M, Lauenstein T C et al.. Comprehensive time-resolved MRI of peripheral vascular malformations. AJR Am J Roentgenol. 2003; 181(3) 729-735
25 Rak K M, Yakes W F, Ray R L et al.. MR imaging of symptomatic peripheral vascular malformations. AJR Am J Roentgenol. 1992; 159(1) 107-112
26 Meyer J S, Hoffer F A, Barnes P D, Mulliken J B. Biological classification of soft-tissue vascular anomalies: MR correlation. AJR Am J Roentgenol. 1991; 157(3) 559-564
27 Buchta K, Sands J, Rosenkrantz H, Roche W. Early mechanism of action of arterially infused alcohol U.S.P. in renal devitalization. Radiology. 1982; 145(1) 45-48
28 Anadon M J, Almendral J, González P et al.. Alcohol concentration determines the type of atrial arrhythmia induced in a porcine model of acute alcoholic intoxication. Pacing Clin Electrophysiol. 1996; 19(11 Pt 2) 1962-1967
29 Chi L M, Wu W G. Mechanism of hemolysis of red blood cell mediated by ethanol. Biochim Biophys Acta. 1991; 1062(1) 46-50
30 Behnia R. Systemic effects of absolute alcohol embolization in a patient with a congenital arteriovenous malformation of the lower extremity. Anesth Analg. 1995; 80(2) 415-417
31 Berenguer B, Burrows P, Zurakowski D, Mulliken J. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg. 1999; 104(1) 1-11 discussion 12-15
32 Lee B B, Do Y S, Byun H S et al.. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg. 2003; 37(3) 533-538
33 Mitchell S E, Shah A M, Schwengel D. Pulmonary artery pressure changes during ethanol embolization procedures to treat vascular malformations: can cardiovascular collapse be predicted?. J Vasc Interv Radiol. 2006; 17(2 Pt 1) 253-262
34 Siniluoto T M, Svendsen P A, Wikholm G M, Fogdestam I, Edström S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (Sotradecol). Scand J Plast Reconstr Surg Hand Surg. 1997; 31(2) 145-150
35 de Lorimier A A. Sclerotherapy for venous malformations. J Pediatr Surg. 1995; 30(2) 188-193 discussion 194
36 Cabrera J, Cabrera J J, Garcia-Olmedo M. Sclerosants in microfoam. A new approach in angiology. Int Angiol. 2001; 20(4) 322-329
37 Sidhu M K, Perkins J A, Shaw D W, Bittles M A, Andrews R T. Ultrasound-guided endovenous diode laser in the treatment of congenital venous malformations: preliminary experience. J Vasc Interv Radiol. 2005; 16(6) 879-884
38 van der Linden E, Overbosch J, Kroft L. Radiofrequency ablation for treatment of symptomatic low-flow vascular malformations after previous unsuccessful therapy. J Vasc Interv Radiol. 2005; 16(5) 747-750
39 Belov S. Anatomopathological classification of congenital vascular defects. Semin Vasc Surg. 1993; 6(4) 219-224
40 Lee B B, Kim Y W, Seo J M et al.. Current concepts in lymphatic malformation. Vasc Endovascular Surg. 2005; 39(1) 67-81
41 Mulliken J B, Fishman S J, Burrows P E. Vascular anomalies. Curr Probl Surg. 2000; 37(8) 517-584
42 Alomari A I, Karian V E, Lord D J, Padua H M, Burrows P E. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol. 2006; 17(10) 1639-1648
43 Sanlialp I, Karnak I, Tanyel F, Senocak M, Büyükpamukçu N. Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol. 2003; 67(7) 795-800
44 Dubois J, Garel L, Abela A, Laberge L, Yazbeck S. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology. 1997; 204(3) 651-654
45 Ogita S, Tsuto T, Deguchi E et al.. OK-432 therapy for unresectable lymphangiomas in children. J Pediatr Surg. 1991; 26(3) 263-268 discussion 268-270
46 Laranne J, Keski-Nisula L, Rautio R, Rautiainen M, Airaksinen M. OK-432 (Picibanil) therapy for lymphangiomas in children. Eur Arch Otorhinolaryngol. 2002; 259(5) 274-278
47 Molitch H I, Unger E C, Witte C L, vanSonnenberg E. Percutaneous sclerotherapy of lymphangiomas. Radiology. 1995; 194(2) 343-347
48 Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg. 1995; 30(9) 1282-1287
49 Shiels 2nd W E, Kenney B, Caniano D, Besner G. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg. 2008; 43(1) 136-139 discussion 140
50 Burrows P E, Laor T, Paltiel H, Robertson R L. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin. 1998; 16(3) 455-488
51 Fishman S J, Mulliken J B. Hemangiomas and vascular malformations of infancy and childhood. Pediatr Clin North Am. 1993; 40(6) 1177-1200
52 Haggstrom A N, Drolet B A Hemangioma Investigator Group et al.. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr. 2007; 150(3) 291-294
53 Frieden I J, Haggstrom A N, Drolet B A et al.. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7–9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol. 2005; 22(5) 383-406
54 Haggstrom A N, Drolet B A, Baselga E et al.. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics. 2006; 118(3) 882-887
55 Ezekowitz R A, Mulliken J B, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992; 326(22) 1456-1463
56 Fishman S J, Burrows P E, Leichtner A M, Mulliken J B. Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities. J Pediatr Surg. 1998; 33(7) 1163-1167
57 Achauer B M, Chang C J, Vander Kam V M. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg. 1997; 99(5) 1301-1308
58 Laor T, Jaramillo D, Hoffer F, Kasser J. MR imaging in congenital lower limb deformities. Pediatr Radiol. 1996; 26(6) 381-387
59 Enjolras O, Wassef M, Mazoyer E et al.. Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas. J Pediatr. 1997; 130(4) 631-640
60 Berenguer B, Mulliken J, Enjolras O et al.. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol. 2003; 6(6) 495-510
61 Enjolras O, Mulliken J, Boon L et al.. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg. 2001; 107(7) 1647-1654
62 Donnelly L F, Adams D M, Bisset G S. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol. 2000; 174(3) 597-608
63 Dubois J, Patriquin H, Garel L et al.. Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography. AJR Am J Roentgenol. 1998; 171(1) 247-252
64 Hovius S E, Borg D H, Paans P R, Pieterman H. The diagnostic value of magnetic resonance imaging in combination with angiography in patients with vascular malformations: a prospective study. Ann Plast Surg. 1996; 37(3) 278-285
65 Kern S, Niemeyer C, Darge K et al.. Differentiation of vascular birthmarks by MR imaging. An investigation of hemangiomas, venous and lymphatic malformations. Acta Radiol. 2000; 41(5) 453-457
66 Konez O, Burrows P, Mulliken J, Fishman S, Kozakewich H. Angiographic features of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol. 2003; 33(1) 15-19
67 Laor T, Burrows P. Congenital anomalies and vascular birthmarks of the lower extremities. Magn Reson Imaging Clin N Am. 1998; 6(3) 497-519
68 Chamlin S, Haggstrom A, Drolet B et al.. Multicenter prospective study of ulcerated hemangiomas. J Pediatr. 2007; 151(6) 684-689
69 Amir J, Metzker A, Krikler R, Reisner S. Strawberry hemangioma in preterm infants. Pediatr Dermatol. 1986; 3(4) 331-332
70 Jacobs A H, Walton R G. The incidence of birthmarks in the neonate. Pediatrics. 1976; 58(2) 218-222
71 Boye E, Yu Y, Paranya G et al.. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest. 2001; 107(6) 745-752
72 Walter J W, North P E, Waner M et al.. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer. 2002; 33(3) 295-303
73 North P E, Waner M, Mizeracki A, Mihm M C. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000; 31(1) 11-22
74 North P E, Waner M, Mizeracki A et al.. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol. 2001; 137(5) 559-570
75 Yu Y, Flint A, Mulliken J, Wu J, Bischoff J. Endothelial progenitor cells in infantile hemangioma. Blood. 2004; 103(4) 1373-1375
76 Dubois J, Milot J, Jaeger B et al.. Orbit and eyelid hemangiomas: is there a relationship between location and ocular problems?. J Am Acad Dermatol. 2006; 55(4) 614-619
77 Haik B G, Jakobiec F A, Ellsworth R M, Jones I S. Capillary hemangioma of the lids and orbit: an analysis of the clinical features and therapeutic results in 101 cases. Ophthalmology. 1979; 86(5) 760-792
78 Stigmar G, Crawford J, Ward C, Thomson H. Ophthalmic sequelae of infantile hemangiomas of the eyelids and orbit. Am J Ophthalmol. 1978; 85(6) 806-813
79 Enjolras O, Riche M, Merland J, Escande J. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics. 1990; 85(4) 491-498
80 Rahbar R, Nicollas R, Roger G et al.. The biology and management of subglottic hemangioma: past, present, future. Laryngoscope. 2004; 114(11) 1880-1891
81 Bitar M A, Moukarbel R V, Zalzal G H. Management of congenital subglottic hemangioma: trends and success over the past 17 years. Otolaryngol Head Neck Surg. 2005; 132(2) 226-231
82 Christison-Lagay E R, Burrows P E, Alomari A et al.. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg. 2007; 42(1) 62-67 discussion 67-68
83 Burrows P E, Dubois J, Kassarjian A. Pediatric hepatic vascular anomalies. Pediatr Radiol. 2001; 31(8) 533-545
84 Boon L M, Burrows P E, Paltiel H J et al.. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr. 1996; 129(3) 346-354
85 Kassarjian A, Dubois J, Burrows P E. Angiographic classification of hepatic hemangiomas in infants. Radiology. 2002; 222(3) 693-698
86 Kassarjian A, Zurakowski D, Dubois J et al.. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol. 2004; 182(3) 785-795
87 Albright A L, Gartner J C, Wiener E S. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics. 1989; 83(6) 977-980
88 Burke D R, Verstandig A, Edwards O et al.. Infantile hemangioendothelioma: angiographic features and factors determining efficacy of hepatic artery embolization. Cardiovasc Intervent Radiol. 1986; 9(3) 154-157
89 Fishman S J, Mulliken J B. Vascular anomalies. A primer for pediatricians. Pediatr Clin North Am. 1998; 45(6) 1455-1477
90 Pope E, Krafchik B, Macarthur C et al.. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics. 2007; 119(6) e1239-e1247
91 Al-Sebeih K, Manoukian J. Systemic steroids for the management of obstructive subglottic hemangioma. J Otolaryngol. 2000; 29(6) 361-366
92 Sadan N, Wolach B. Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr. 1996; 128(1) 141-146
93 Boon L M, MacDonald D M, Mulliken J B. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg. 1999; 104(6) 1616-1623
94 George M E, Sharma V, Jacobson J, Simon S, Nopper A J. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol. 2004; 140(8) 963-969
95 Kushner B J. The treatment of periorbital infantile hemangioma with intralesional corticosteroid. Plast Reconstr Surg. 1985; 76(4) 517-526
96 Sloan G M, Reinisch J F, Nichter L S et al.. Intralesional corticosteroid therapy for infantile hemangiomas. Plast Reconstr Surg. 1989; 83(3) 459-467
97 Greinwald J H, Burke D K, Bonthius D J, Bauman N M, Smith R J. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg. 1999; 125(1) 21-27
98 Enjolras O, Brevière G M, Roger G et al.. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr. 2004; 11(2) 99-107
99 Perez J, Pardo J, Gomez C. Vincristine–an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol. 2002; 41(2) 197-199
100 Fawcett S L, Grant I, Hall P N, Kelsall A W, Nicholson J C. Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg. 2004; 57(2) 168-171
101 David L R, Malek M M, Argenta L C. Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg. 2003; 56(4) 317-327
102 Gupta G, Bilsland D. A prospective study of the impact of laser treatment on vascular lesions. Br J Dermatol. 2000; 143(2) 356-359
103 Poetke M, Philipp C, Berlien H. Flashlamp-pumped pulsed dye laser for hemangiomas in infancy: treatment of superficial vs mixed hemangiomas. Arch Dermatol. 2000; 136(5) 628-632
104 Waner M, Suen J, Dinehart S, Mallory S. Laser photocoagulation of superficial proliferating hemangiomas. J Dermatol Surg Oncol. 1994; 20(1) 43-46
105 Batta K, Goodyear H, Moss C et al.. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet. 2002; 360(9332) 521-527
106 Burrows P E, Rosenberg H, Chuang H. Diffuse hepatic hemangiomas: percutaneous transcatheter embolization with detachable silicone balloons. Radiology. 1985; 156(1) 85-88
107 Johnson D H, Vinson A M, Wirth F H et al.. Management of hepatic hemangioendotheliomas of infancy by transarterial embolization: a report of two cases. Pediatrics. 1984; 73(4) 546-549
108 Warmann S, Bertram H, Kardorff R et al.. Interventional treatment of infantile hepatic hemangioendothelioma. J Pediatr Surg. 2003; 38(8) 1177-1181
109 Holcomb 3rd G W, O'Neill Jr J A, Mahboubi S, Bishop H C. Experience with hepatic hemangioendothelioma in infancy and childhood. J Pediatr Surg. 1988; 23(7) 661-666
110 Stanley P, Grinnell V, Stanton R, Williams K, Shore N. Therapeutic embolization of infantile hepatic hemangioma with polyvinyl alcohol. AJR Am J Roentgenol. 1983; 141(5) 1047-1051
111 Jianhong L, Xianliang H, Xuewu J. Transcatheter arterial embolization in the treatment of extensive maxillofacial hemangioma in children. World J Surg. 2005; 29(12) 1550-1556
112 Andronikou S, Mandelstam S, Fasulakis S. MRI and preoperative embolization of a nasal cavity haemangioma in a child. Australas Radiol. 2003; 47(4) 386-388
113 Konior R J, Holinger L D, Russell E J. Superselective embolization of laryngeal hemangioma. Laryngoscope. 1988; 98(8 Pt 1) 830-834
114 Burrows P E, Lasjaunias P, Ter Brugge K, Flodmark O. Urgent and emergent embolization of lesions of the head and neck in children: indications and results. Pediatrics. 1987; 80(3) 386-394
115 Kaneko R, Tohnai I, Ueda M et al.. Curative treatment of central hemangioma in the mandible by direct puncture and embolisation with n-butyl-cyanoacrylate (NBCA). Oral Oncol. 2001; 37(7) 605-608
116 O'Donovan J C, Donaldson J S, Morello F P et al.. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol. 1997; 169(3) 723-729
117 Hayashi N, Masumoto T, Okubo T et al.. Hemangiomas in the face and extremities: MR-guided sclerotherapy–optimization with monitoring of signal intensity changes in vivo. Radiology. 2003; 226(2) 567-572
118 Winter H, Dräger E, Sterry W. Sclerotherapy for treatment of hemangiomas. Dermatol Surg. 2000; 26(2) 105-108
119 Zukerberg L R, Nickoloff B J, Weiss S W. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol. 1993; 17(4) 321-328
120 Lyons L L, North P E, Mac-Moune Lai F et al.. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol. 2004; 28(5) 559-568
121 Enjolras O, Mulliken J, Wassef M et al.. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol. 2000; 42(2 Pt 1) 225-235
122 Gruman A, Liang M, Mulliken J et al.. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol. 2005; 52(4) 616-622
123 Hauer J, Graubner U, Konstantopoulos N et al.. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen. Pediatr Blood Cancer. 2007; 49(6) 852-854
124 Harper L, Michel J, Enjolras O et al.. Successful management of a retroperitoneal kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using alpha-interferon. Eur J Pediatr Surg. 2006; 16(5) 369-372
125 Haisley-Royster C, Enjolras O, Frieden I et al.. Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol. 2002; 24(6) 459-462

Sandeep VaidyaM.D.

Assistant Professor, Department of Radiology, University of Washington

1959 NE Pacific Street, Box #357115, Seattle, WA 98195

Email: svaidya@u.washington.edu